We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Blood Test Device Proven in the Field

By LabMedica International staff writers
Posted on 02 Jul 2014
Print article
Image: The AtomoRapid device for testing for human immunodeficiency virus (HIV) (Photo courtesy of Atomo Diagnostics).
Image: The AtomoRapid device for testing for human immunodeficiency virus (HIV) (Photo courtesy of Atomo Diagnostics).
A blood testing platform has been introduced that accommodates test strips for a wide variety of conditions from celiac disease, allergy through to infectious diseases such as malaria and human immunodeficiency virus (HIV).

The blood test device AtomoRapid HIV has been awarded Best in Show, and the winner of the In Vitro Diagnostics Category, at the Medical Design Excellence Awards (MDEA), held June 11, 2014, in New York (NY, USA).

The company that manufactures the AtomoRapid device is Atomo Diagnostics (Sydney, Australia) is an award-winning based healthcare company with a focus on product development and usability. Atomo develops and commercializes next generation solutions that address unmet user needs in the diagnostic industry.

The AtomoRapid HIV test uses a World Health Organization (WHO; Geneva, Switzerland) prequalified, antibody test for the detection of HIV 1&2 in human whole blood, serum or plasma. It is a highly sensitive screening test that performs well when deployed in the field. Given its ease of use and simplicity, AtomoRapid HIV has the ability to materially improve both the uptake and reliability of HIV testing in the community and at home. AtomoRapid HIV test is currently available for sale in several African countries from their South Africa office. AtomoRapid Malaria, the second test to market, will be available in the 3rd Quarter of 2014 and they plan to introduce additional tests in the coming 18 months.

John Kelly, B.Eng, MSc, EMBA, Founder and CEO of Atomo Diagnostics, said, “Clinical performance of standard test kits is proven in the laboratory, but serious concerns have been raised about in-field performance. This is down to their complex nature, requiring multiple components for the procedure offering resulting in errors, which in turn creates false diagnosis. For a disease such as HIV, this can have significant impact not only on the individual, but the community too.”

Related Links:

Medical Design Excellence Awards 
Atomo Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.